Download GlobalData’s Covid-19 Executive Briefing report
- ECONOMIC IMPACT -
Latest update: 15 September
The global economy is forecasted to return to pre-crisis levels by the end of 2021 or early 2022.
According to Statistics South Africa, real GDP in the nation expanded by 1.2% in Q2 2021.
The unemployment rate in OECD nations stood at 6.2% in July 2021, down from 6.4% in June 2021.
World economic growth is projected at 5.7% in 2021 and at 4.5% in 2022, according to HIS Markit.
Impact of Covid-19 on equity indices
- SECTOR IMPACT: PHARMA -
Latest update: 03 September
Currently, there are 5,746 clinical trials for Covid-19 and promising clinical data continues to emerge for Covid-19 vaccines.
Trial disruption is levelling off, with 1,052 trials still disrupted and 627 pharma/biotech companies and clinical research organisations associated with disrupted trials.
With multiple vaccines having shown impressive efficacy, notably for reductions in the need for hospitalisation and mortality, the window for utility for Covid-19 therapies may be rapidly contracting.
However, this may be offset increased illness caused by the rise of vaccine-resistant variants and shortages of vaccines in certain countries, such as India.
Low vaccination rates in localised areas could lead to ‘hyperlocal outbreaks’ where communities surrounded by high vaccination areas could experience outbreaks in localised clusters.
Key pharma market developments